Autoimmune hepatitis following mRNA COVID-19 vaccine

Therapie. 2023 Nov-Dec;78(6):760-761. doi: 10.1016/j.therap.2022.12.014. Epub 2023 Aug 29.

¹ National Center Chalbi Belkahia of Pharmacovigilance, 1006, Tunis, Tunisia; Research unit: UR17ES12, Faculty of Medicine, University of Tunis El Manar, La Rabta, 1007 Tunis, Tunisia. Electronic address: ahmed.zaiem@rns.tn.
² Research unit: UR17ES12, Faculty of Medicine, University of Tunis El Manar, La Rabta, 1007 Tunis, Tunisia.
³ National Center Chalbi Belkahia of Pharmacovigilance, 1006, Tunis, Tunisia; Research unit: UR17ES12, Faculty of Medicine, University of Tunis El Manar, La Rabta, 1007 Tunis, Tunisia.
⁴ National Center Chalbi Belkahia of Pharmacovigilance, 1006, Tunis, Tunisia.
⁵ Gastroenterology Department, Mahmoud Matri Hospital, 2080 Ariana, Tunisia.

No abstract available

Keywords: Adverse drug reaction; Adverse effects following immunization; Autoimmune disease; COVID-19 vaccine; Hepatitis; Pharmacovigilance.

Publication types